Trials / Completed
CompletedNCT03195959
Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension
Effect of Normobaric Hypoxia and Hyperoxia on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary Hypertension (PH) is a severe disease with a bad prognosis. However, thanks to extensive research in this field, there are more and better treatment options that allow patients to participate in recreational activities at moderate altitude or bring up the question of air-travel. Still very few is known about the effects hypoxic conditions have on PH patients. The aim of this study is to investigate the effects of hypoxia in comparison to normoxia and hyperoxia on pulmonary hemodynamics in patients with pulmonary hypertension during routine right heart catheterisation. We aim to get insight into the pathophysiology of pulmonary hemodynamics under hypoxic conditions in comparison to normoxia and hyperoxia in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension compared with control patients, that are scheduled for right heart catheterisation due to dyspnea but have no PH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hypoxia and Hyperoxia | 10 minutes of breathing a gas mixture with FiO2 0.16 via a tight fitting mask. After 10 minutes of breathing ambient air (normoxia), patients were exposed to hyperoxia (FiO2 1.0) for 10 minutes. |
Timeline
- Start date
- 2017-06-22
- Primary completion
- 2022-05-01
- Completion
- 2022-05-01
- First posted
- 2017-06-22
- Last updated
- 2022-11-02
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03195959. Inclusion in this directory is not an endorsement.